What is it about?

It's research involving two drugs such as DULOXETINE and GABAPENTIN. We compare the two drugs for the pain in diabetic neuropathy patient's. It is open label, randomized controlled trial. We compare the efficacy by evaluating pain scores. We found that two drugs are decrease the pain substantially with minimal side effects.

Featured Image

Why is it important?

As this is RCT, DULOXETINE and GABAPENTIN never compared head to head for painful diabetic neuropathy patients. So we found that both the drugs show comparable efficacy with minimal side effect profile.

Perspectives

As it is most diabetic neuropathy is most prevalent complications of type 2 diabetes mellitus. It decreases the quality of life. So in understanding with this we have done this trial. It's findings are interesting and more related to real world problems.

SAMEER KHASBAGE
ALL INDIA INSTITUTE OF MEDICAL SCIENCES, BHOPAL

Read the Original

This page is a summary of: A randomized control trial of duloxetine and gabapentin in painful diabetic neuropathy, Journal of Diabetes, January 2021, Wiley, DOI: 10.1111/1753-0407.13148.
You can read the full text:

Read

Contributors

The following have contributed to this page